» Articles » PMID: 8602004

Polymorphism in Serotonin Transporter Gene Associated with Susceptibility to Major Depression

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1996 Mar 16
PMID 8602004
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: BACKGROUND; The serotonin transporter of the brain provides the primary target for the action of selective antidepressant drugs. We set out to identify polymorphisms of the serotonin transporter gene and to find out whether there was a relation between any such polymorphisms and the occurrence of affective disorder.

Methods: A comparison of a polymorphic region of the human serotonin transporter gene was carried out between two groups. The study group comprised 83 patients (39 unipolar depressive disorder, 44 bipolar disorder) with major affective disorder. The control group comprised 122 anonymous blood donors, and 71 volunteers who had been screened for psychiatric disorders.

Findings: We detected three novel alleles of the variable-number-tandem-repeat (VNTR) region (STin2.9, STin2.10) and Stin2.12) containing nine, ten and 12 copies of the VNTR element, respectively. The frequencies of the different forms of the allele in the control group were compared with those in the affective disorder group. There was a significant difference between the control and affective disorder groups, largely explained by the excess of the STin2.9 allele in the unipolar group (chi2=10.05, p<0.004 [Bonferroni corrected]). The presence of the allele with nine copies of the repeat was significantly associated with risk of unipolar disorder (odds ratio=6.95 [95% CI 1.8-27.2]).

Interpretation: This association, for an obvious candidate gene, may provide a critical starting point for an understanding of the likely polygenic contributions towards susceptibility to affective disorder.

Citing Articles

Not Just a Mood Disorder─Is Depression a Neurodevelopmental, Cognitive Disorder? Focus on Prefronto-Thalamic Circuits.

Soto N, Gaspar P, Bacci A ACS Chem Neurosci. 2024; 15(8):1611-1618.

PMID: 38580316 PMC: 11027097. DOI: 10.1021/acschemneuro.3c00828.


Elucidation of Pharmacological Mechanism Underlying the Anti-Alzheimer's Disease Effects of and Discovery of Novel Lead Molecules: An In Silico Study.

Zhang L, Xu J, Guo J, Wang Y, Wang Q Molecules. 2023; 28(15).

PMID: 37570816 PMC: 10421504. DOI: 10.3390/molecules28155846.


Genetic polymorphisms in the serotonin, dopamine and opioid pathways influence social attention in rhesus macaques (Macaca mulatta).

Howarth E, Szott I, Witham C, Wilding C, Bethell E PLoS One. 2023; 18(8):e0288108.

PMID: 37531334 PMC: 10395878. DOI: 10.1371/journal.pone.0288108.


Postpartum depression: aetiology, pathogenesis and the role of nutrients and dietary supplements in prevention and management.

Rupanagunta G, Nandave M, Rawat D, Upadhyay J, Rashid S, Ansari M Saudi Pharm J. 2023; 31(7):1274-1293.

PMID: 37304359 PMC: 10250836. DOI: 10.1016/j.jsps.2023.05.008.


Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response Markers.

Singh P, Srivastava A, Guin D, Thakran S, Yadav J, Chandna P Int J Neuropsychopharmacol. 2023; 26(10):692-738.

PMID: 36655406 PMC: 10586057. DOI: 10.1093/ijnp/pyad001.